- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Antifungal resistance.
Displaying page 1 of 1.
EudraCT Number: 2017-003571-56 | Sponsor Protocol Number: APX001-201 | Start Date*: 2018-12-17 | |||||||||||
Sponsor Name:Amplyx Pharmaceuticals, Inc. | |||||||||||||
Full Title: An Open-Label Study to Evaluate the Efficacy and Safety of APX001 in Non-Neutropenic Patients with Candidemia, with or without Invasive Candidiasis, Inclusive of Patients with Suspected Resistance ... | |||||||||||||
Medical condition: Treatment of non-neutropenic subjects with candidemia – inclusive of those subjects with suspected or confirmed antifungal-resistant candidemia with or without invasive candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002644-23 | Sponsor Protocol Number: MB_PDT_1 | Start Date*: 2020-07-23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Dept. of Dermatology, Zealand University Hospital, Roskilde | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Photodynamic therapy of antifungal resistant dermatophytes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Competent patients over 18 years old with mycological verified antifungal resistant dermatophytosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000627-40 | Sponsor Protocol Number: IA-DUET | Start Date*: 2020-12-28 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial (IA-DUET) | |||||||||||||
Medical condition: Invasive aspergillosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001386-33 | Sponsor Protocol Number: APX001-202 | Start Date*: 2019-08-20 | |||||||||||
Sponsor Name:Amplyx Pharmaceuticals, Inc., a wholly owned subsidiary of Pfizer, Inc. | |||||||||||||
Full Title: A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of APX001 in the Treatment of Patients with Invasive Mold Infections Caused by Aspergillus Species or Rare Molds | |||||||||||||
Medical condition: Treatment of patients with invasive mold infections (IMIs) caused by Aspergillus species (spp.) or rare molds | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000381-29 | Sponsor Protocol Number: SCY-078-301 | Start Date*: 2017-07-17 |
Sponsor Name:SCYNEXIS, Inc. | ||
Full Title: Open-Label Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients with Fungal Diseases that are Refractory to, Resistant to or Intolerant of Standard Antifungal Treatment (FURI) | ||
Medical condition: Patients > 18 years of age with a documented invasive and/or severe fungal disease that has been intolerant, resistant or refractory (rIFI) to Standard of Care (SoC) antifungal treatment. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) ES (Ongoing) GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2005-004211-30 | Sponsor Protocol Number: 2005-23 | Start Date*: 2005-10-17 |
Sponsor Name:The Norwegian Radium Hospital | ||
Full Title: Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia | ||
Medical condition: Lymphoma and leukemia patients with febrile neutropenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003921-40 | Sponsor Protocol Number: 2016IF002 | Start Date*: 2017-07-21 | |||||||||||||||||||||||||||||||
Sponsor Name:University Hospital of South Manchester NHS Foundation Trust | |||||||||||||||||||||||||||||||||
Full Title: Open label study of the efficacy and safety of isavuconazole for the treatment of Chronic Pulmonary Aspergillosis | |||||||||||||||||||||||||||||||||
Medical condition: Chronic Pulmonary Aspergillosis | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-000386-32 | Sponsor Protocol Number: F901318/0041 | Start Date*: 2022-01-21 | |||||||||||
Sponsor Name:F2G Ltd. | |||||||||||||
Full Title: A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with... | |||||||||||||
Medical condition: invasive fungal infections due to Aspergillus spp. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) FR (Trial now transitioned) BE (Trial now transitioned) NL (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001290-17 | Sponsor Protocol Number: F901318/0032 | Start Date*: 2018-03-30 |
Sponsor Name:F2G Biotech GmbH (FN 483749 x) | ||
Full Title: An open-label single-arm Phase IIb study of F901318 as treatment of invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi in pat... | ||
Medical condition: invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) ES (Ongoing) NL (Completed) DE (Completed) GB (GB - no longer in EU/EEA) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004599-19 | Sponsor Protocol Number: INTERFANT-06 | Start Date*: 2005-11-24 | |||||||||||
Sponsor Name:A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA | |||||||||||||
Full Title: INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA | |||||||||||||
Medical condition: acute lymphoblastic leukemia (ALL) or biphenotypic leukemia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) BE (Completed) FR (Ongoing) DE (Completed) GB (Completed) AT (Ongoing) PT (Completed) DK (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
